These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4966651)

  • 1. [Preliminary observations on the changes of renal function and blood coagulation processes in normal aged subjects and those with vascular diseases treated with large subintrant doses of hydergine].
    Aradas A
    G Gerontol; 1966 Dec; 14(12):1155-62. PubMed ID: 4966651
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electroencephalographic findings in cerebral vascular diseases in aged patients and their changes under the influence of sympatholytic (Hydergine) therapy].
    Kauchtschischwili GM; Pontiggia M; Zerbi F
    Riv Neurol; 1967; 37(3):231-50. PubMed ID: 4965103
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood coagulation disorders in patients with chronic renal insufficiency].
    Follana R; Salvadori JM; Olmer M
    J Urol Nephrol (Paris); 1972 Dec; 78(12):1004-7. PubMed ID: 4267518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fibrinolysis in chronic renal insufficiency treated wth periodic hemodialysis].
    Triolo R; Cavagnino A; Cavalli PL
    Minerva Med; 1972 Sep; 63(68):3704-12. PubMed ID: 5071959
    [No Abstract]   [Full Text] [Related]  

  • 5. Symptomatic treatment of cerebrovascular insufficiency with hydergine.
    Gerin J
    Curr Ther Res Clin Exp; 1969 Sep; 11(9):539-46. PubMed ID: 4980884
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of hydergine in the vertebro-basilar vascular insufficiency syndrome of cervical origin].
    Sánchez Dueñas M
    Rev Esp Otoneurooftalmol Neurocir; 1970; 28(161):41-6. PubMed ID: 4999170
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electroencephalographic findings in the course of cerebrovascular diseases in aged subjects and their changes under the influence of sympathicolytic therapy (hydergine)].
    Kauchtschischwili GM; Pontiggia M; Zerbi F
    G Gerontol; 1966 Dec; 14(12):1221-5. PubMed ID: 4966653
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hydergine in the treatment of chronic psychoses].
    Bohard F; Guennoc A; Klein H; Le Borgne Y; Masanes P
    Ann Med Psychol (Paris); 1967 Mar; 125(3):438-46. PubMed ID: 4964710
    [No Abstract]   [Full Text] [Related]  

  • 9. [Coagulation and fibrinolysis alterations in renal failure (author's transl)].
    Rocha E; Sánchez Ibarrola A; Arrizabalaga B; Páramo JA; Purroy A
    Sangre (Barc); 1980; 25(5B):740-59. PubMed ID: 7008223
    [No Abstract]   [Full Text] [Related]  

  • 10. [Attempt at psychometric evaluation of aging: study of a vascular drug].
    Losson M; Losson JP
    Therapeutique; 1969 Mar; 45(3):313-7. PubMed ID: 4989246
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined treatment with hydergine and neuroleptics in mental disorders of old age].
    Bukowczyk A; Wasik A; Horodnicki J
    Psychiatr Pol; 1969; 3(3):327-32. PubMed ID: 4980081
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes of the cerebral circulation time influenced by hydergine].
    Herzfeld U; Wittgen M
    Arztl Forsch; 1971 Jul; 25(7):224-30. PubMed ID: 4998670
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic effects of hydergine in mental disorders in the involutional age].
    Bonasera N; Smorto M; Scialfa G
    Osp Psichiatr; 1968; 36(1):75-87. PubMed ID: 4988290
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes of blood coagulation in patients with chronic kidney diseases and hemodialysis].
    Saggau W; Encke A
    Med Welt; 1972 Jan; 23(3):91-4. PubMed ID: 5018430
    [No Abstract]   [Full Text] [Related]  

  • 15. [Platelet aggregation, erythrocyte filterability and changes of some blood coagulation parameters in subjects with chronic obstructive arteriopathy of the lower limbs].
    Macchione C; Neirotti M; Longo F; Friziero M; Molaschi M; Poli L
    Minerva Cardioangiol; 1983; 31(7-8):433-8. PubMed ID: 6646445
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of hydergine on the functional manifestations of encephalic vasomotricity].
    Memin Y; Rigal P
    Lyon Med; 1971 Jun; 225(11):1177-82. PubMed ID: 4997290
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of patients with cerebral and diffuse arteriosclerosis with hydergine].
    Avena G
    Hospital (Rio J); 1970 Sep; 78(3):901-28. PubMed ID: 4994595
    [No Abstract]   [Full Text] [Related]  

  • 18. [Erythrocyte sludging and hydergine].
    Minerva Anestesiol; 1966 Jan; 32(1):58-60. PubMed ID: 4956155
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic findings in 23 geriatric cases treated with hydergine (clinical note)].
    Tessler D
    Hospital (Rio J); 1970 Jul; 78(1):267-70. PubMed ID: 4991827
    [No Abstract]   [Full Text] [Related]  

  • 20. Utilization of thioridazine combined with hydergine in the treatment of incipient mental disturbances in cerebral atherosclerosis.
    Predescu V; Ciurezu T; Nica S; Ionescu R; Tudorache D; Niţurad A; Oproiu L; Popovici I; Curelaru S; Roman I
    Rev Roum Neurol Psychiatr; 1974; 11(3):243-8. PubMed ID: 4211107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.